The Academy is recommending that both males and females be vaccinated routinely against oncogenic human papillomavirus (HPV) strains.

The recommendations are outlined in the policy statement HPV Vaccine Recommendations published in the March issue of Pediatrics (2012;129:602-605,http://pediatrics.aappublications.org/cgi/doi/10.1542/peds.2011-3865).

Since the last AAP policy statement on HPV vaccination was published in 2007, the Food and Drug Administration added indications for the quadrivalent human papillomavirus vaccine (HPV4 [Gardasil, Merck & Co. Inc.]) to include prevention of warts in adolescent males (2009) and prevention of anal cancers in males and females (2010).

In December 2011, the Centers for Disease Control and Prevention (CDC) recommended that males ages 11 or 12 years routinely receive a three-dose series of quadrivalent HPV vaccine. This recommendation closely parallels the 2006 CDC recommendation for HPV vaccination in females ages 11 or 12 years, using either bivalent or quadrivalent HPV vaccines. There are subtle differences between genders in...

You do not currently have access to this content.